share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  04/25 05:06

牛牛AI助理已提取核心訊息

Conduit Pharmaceuticals Inc. (CDT.US) has reported a transaction involving Farley Chele Chiavacci, a key figure associated with the company. The transaction, which took place on April 22, 2024, did not specify the relationship of Chiavacci to the issuer. Details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed in the announcement.
Conduit Pharmaceuticals Inc. (CDT.US) has reported a transaction involving Farley Chele Chiavacci, a key figure associated with the company. The transaction, which took place on April 22, 2024, did not specify the relationship of Chiavacci to the issuer. Details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed in the announcement.
Conduit Pharmicals Inc.(CDT.US)報告了一筆涉及與該公司相關的關鍵人物法利·切爾·基亞瓦奇的交易。該交易於2024年4月22日進行,沒有具體說明基亞瓦奇與發行人的關係。公告中沒有披露有關交易性質的細節,例如所涉及的股票數量、交易價格和由此產生的股權。
Conduit Pharmicals Inc.(CDT.US)報告了一筆涉及與該公司相關的關鍵人物法利·切爾·基亞瓦奇的交易。該交易於2024年4月22日進行,沒有具體說明基亞瓦奇與發行人的關係。公告中沒有披露有關交易性質的細節,例如所涉及的股票數量、交易價格和由此產生的股權。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。